ArticleCancers2020

An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients.

Jiacong Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.